RxDoctor Payments Data

Vanessa Blumer

Advanced Heart Failure and Transplant Cardiology · Falls Church, VANPI 1659765089

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,747 of the $2,268 with a category attached, or 77.0%. Abbott accounts for 71.3% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2024 at $739 and has fallen 53.9% since, to $341 in 2025. That places this record below the midpoint for advanced heart failure and transplant cardiology clinicians in VA, where the typical reported total is $4,498.

$2,268in general payments, 2019–2025

Across 31 payments — averaging $73.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$2K
  • Abiomed$267
  • Medtronic$259
  • AstraZeneca$30
  • Merck$25
  • Boston Scientific$24
  • plus $46 from 2 others

What the payments were for

  • Travel & lodging$52123%
  • Food & beverage$1,74777%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Abbott18$1,617
Abiomed6$267
Medtronic2$259
AstraZeneca1$30
Merck1$25
Boston Scientific1$24
Recor Medical Inc1$23
Novo Nordisk1$22

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,268 in reported general payments places this provider in the 30th percentile of 43 advanced heart failure and transplant cardiology providers in Virginia.

See all advanced heart failure and transplant cardiology providers in Virginia

Medicare billing

Part B allowed, 2024
$44,022
Medicare patients
105
Services billed
282

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin27$28,825
EntrestoSacubitril/Valsartan25$24,533
FarxigaDapagliflozin Propanediol11$7,868
Valsartan14$444
Spironolactone41$312
Metoprolol Succinate12$163
Furosemide21$99
Carvedilol13$71

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga$30$7,86811 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 30th percentile of 43 advanced heart failure and transplant cardiology providers in Virginia.

Other advanced heart failure and transplant cardiology in Falls Church

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →